Supplementary Table 1. Switch rates and total cost associated with apremilast and biologics in biologic-naive patients with psoriatic arthritis.
dataset
posted on 2021-06-30, 08:45 authored by David L Kaplan, Brian L Ung, Corey Pelletier, Chuka Udeze, Ibrahim Khilfeh, Marc TianSupplementary Table 1. Treatment switch details.
Funding
This study was funded by Celgene
History
Usage metrics
Categories
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC